Literature DB >> 18295490

Synthesis of curcumin mimics with multidrug resistance reversal activities.

Yumi Um1, Sungsik Cho, Ho Bum Woo, Yong Kee Kim, Hanna Kim, Jungyeob Ham, Su-Nam Kim, Chan Mug Ahn, Seokjoon Lee.   

Abstract

In order to discover novel multidrug resistance (MDR) reversal agents for efficient cancer chemotherapy, the unsymmetrical curcumin mimics with various amide moieties (6-19) were synthesized and evaluated their MDR reversal activities in MDR cell line KBV20C. Among the tested compounds, 13, 16, and 17 showed potent MDR reversal activities by inhibiting drug efflux function of P-glycoprotein in KB20C cells, and almost recovered the cytotoxicity of vincristine and paclitaxel against KBV20C cell to the degree of potency against drug sensitive KB cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18295490     DOI: 10.1016/j.bmc.2008.02.012

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

Review 1.  Curcumin nanoformulations: a future nanomedicine for cancer.

Authors:  Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Drug Discov Today       Date:  2011-09-18       Impact factor: 7.851

2.  Design of curcumin loaded cellulose nanoparticles for prostate cancer.

Authors:  Murali Mohan Yallapu; Mitch Ray Dobberpuhl; Diane Michele Maher; Meena Jaggi; Subhash Chand Chauhan
Journal:  Curr Drug Metab       Date:  2012-01       Impact factor: 3.731

3.  Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines.

Authors:  Stella Chai; Kenneth Kw To; Ge Lin
Journal:  Chin Med       Date:  2010-07-25       Impact factor: 5.455

Review 4.  Curcumin as a Modulator of P-Glycoprotein in Cancer: Challenges and Perspectives.

Authors:  Vanessa Lopes-Rodrigues; Emília Sousa; M Helena Vasconcelos
Journal:  Pharmaceuticals (Basel)       Date:  2016-11-10

5.  An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells.

Authors:  Fatemeh Abedi; Soodabeh Davaran; Malak Hekmati; Abolfazl Akbarzadeh; Behzad Baradaran; Sevil Vaghefi Moghaddam
Journal:  J Nanobiotechnology       Date:  2021-01-09       Impact factor: 10.435

Review 6.  A neutraceutical by design: the clinical application of curcumin in colonic inflammation and cancer.

Authors:  D Soni; B Salh
Journal:  Scientifica (Cairo)       Date:  2012-09-03

7.  Curcumin Regulates Colon Cancer by Inhibiting P-Glycoprotein in In-situ Cancerous Colon Perfusion Rat Model.

Authors:  Prasad Neerati; Yakkanti A Sudhakar; Jagat R Kanwar
Journal:  J Cancer Sci Ther       Date:  2013-07-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.